NEW YORK (GenomeWeb) – Genomics England, which is heading the UK's 100,000 Genomes Project, today named 10 firms it has selected to continue to the next assessment phase of the project.

The companies are Congenica; Diploid; NantOmics; Genomics Ltd.; Illumina; Qiagen; Lockheed Martin; NextCode Health; Omicia; and Personalis. Each company will move on to the next stage of the selection process as Genomics England evaluates genomic service providers for the 100,000 Genomes Project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.